Seeing Is Believing

Currently out of the existing stock ratings of Jason Butler, 289 are a BUY (94.14%), 17 are a HOLD (5.54%), 1 are a SELL (0.33%).
Analyst Jason Butler, currently employed at JMP, carries an average stock price target met ratio of 41.07% that have a potential upside of 62.72% achieved within 243 days.
Jason Butler’s has documented 575 price targets and ratings displayed on 51 stocks. The coverage is on Healthcare, Industrials, Consumer Cyclical, Technology sectors.
Most recent stock forecast was given on PGEN, Precigen at 26-Mar-2026.
Analyst best performing recommendations are on ABVX (ABIVAX SA AMERICAN DEPOSITARY SHARES).
The best stock recommendation documented was for ABVX (ABIVAX SA AMERICAN DEPOSITARY SHARES) at 7/14/2025. The price target of $33 was fulfilled within 9 days with a profit of $24.17 (273.73%) receiving and performance score of 304.14.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Apr-2025
$36
$10.13 (39.16%)
$26
12 days ago
(21-Jul-2026)
4/5 (80%)
$10.57 (41.57%)
144
Hold Since 20-Jun-2022
$25
$-0.87 (-3.36%)
$24
12 days ago
(21-Jul-2026)
18/20 (90%)
$-0.43 (-1.69%)
119
Buy Since 23-Jun-2025
$36
$10.13 (39.16%)
$30
26 days ago
(07-Jul-2026)
0/7 (0%)
$9.8 (37.40%)
Buy Since 30-Jun-2026
$30
$4.13 (15.96%)
$29
1 months 3 days ago
(30-Jun-2026)
10/13 (76.92%)
$4.7 (18.58%)
275
Buy Since 21-Oct-2025
$35
$9.13 (35.29%)
$32
1 months 4 days ago
(29-Jun-2026)
0/4 (0%)
$9.8 (38.89%)
Which stock is Jason Butler is most bullish on?
Which stock is Jason Butler is most reserved on?
What Year was the first public recommendation made by Jason Butler?